Cargando…

miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met

Gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, is used as a first-line treatment for advanced non-small cell lung cancer (NSCLC). However, most NSCLC patients inevitably develop gefitinib resistance, and the mechanisms underlying this resistance are not fully unders...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Xiaonian, Lai, Senyan, Hu, Fayong, Li, Guodong, Wang, Guihua, Luo, Xuelai, Fu, Xiangning, Hu, Junbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462753/ https://www.ncbi.nlm.nih.gov/pubmed/28592790 http://dx.doi.org/10.1038/s41598-017-01153-0

Ejemplares similares

KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors
por: Lai, Senyan, et al.
Publicado: (2015)

Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification
por: La Monica, Silvia, et al.
Publicado: (2013)

Inhibition of GPR30 sensitized gefitinib to NSCLC cells via regulation of epithelial-mesenchymal transition
por: Yang, Xiaomin, et al.
Publicado: (2023)

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
por: Hu, Yong, et al.
Publicado: (2017)

Triptolide inhibits epithelial-mesenchymal transition and induces apoptosis in gefitinib-resistant lung cancer cells
por: Li, Fangqiong, et al.
Publicado: (2020)

Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling
por: Hu, Fuqing, et al.
Publicado: (2018)

Correction to: Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling
por: Hu, Fuqing, et al.
Publicado: (2018)

LncRNA HOTAIR/miR‐613/c‐met axis modulated epithelial‐mesenchymal transition of retinoblastoma cells
por: Yang, Ge, et al.
Publicado: (2018)

Lentivirus-mediated silencing of CNTN1 enhances gefitinib sensitivity by reversing epithelial-mesenchymal transition in lung adenocarcinoma A549 cells
por: Hu, Chun-Sheng, et al.
Publicado: (2021)

A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling
por: Spooner-Harris, Madelyn, et al.
Publicado: (2022)

HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer
por: Yin, Jun, et al.
Publicado: (2019)

GW4869 Can Inhibit Epithelial-Mesenchymal Transition and Extracellular HSP90α in Gefitinib-Sensitive NSCLC Cells
por: Wan, Xuan, et al.
Publicado: (2023)

Expression of HAX-1 in colorectal cancer and its role in cancer cell growth
por: LI, XIAOLAN, et al.
Publicado: (2015)

Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling
por: Lee, Jin-Ku, et al.
Publicado: (2014)

Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer
por: Sylvester, Paul W
Publicado: (2014)

Modeling of mesenchymal hybrid epithelial state and phenotypic transitions in EMT and MET processes of cancer cells
por: He, Peng, et al.
Publicado: (2018)

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
por: Yoshida, T, et al.
Publicado: (2014)

High-level gain of mesenchymal-epithelial transition factor (MET) copy number using next-generation sequencing as a predictive biomarker for MET inhibitor efficacy
por: Wu, Shibo, et al.
Publicado: (2020)

Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma
por: Yu, Hongmin, et al.
Publicado: (2023)

The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
por: Demirkan, Binnaz
Publicado: (2013)

MiR-23b-3p suppresses epithelial-mesenchymal transition, migration, and invasion of hepatocellular carcinoma cells by targeting c-MET
por: Park, Na Ri, et al.
Publicado: (2022)

Serine/threonine-protein kinase STK24 induces tumorigenesis by regulating the STAT3/VEGFA signaling pathway
por: Lai, Senyan, et al.
Publicado: (2023)

SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer
por: Li, Guodong, et al.
Publicado: (2017)

Effects of cilengitide derivatives on TGF-β1-induced epithelial-to-mesenchymal transition and invasion in gefitinib-resistant non-small cell lung cancer cells
por: Seo, Yujin, et al.
Publicado: (2023)

PIK3R3 regulates PPARα expression to stimulate fatty acid β-oxidation and decrease hepatosteatosis
por: Yang, Xi, et al.
Publicado: (2018)

The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells
por: Cheng, Yu, et al.
Publicado: (2018)

Acceleration of Mesenchymal-to-Epithelial Transition (MET) during Direct Reprogramming Using Natural Compounds
por: Seo, Ji-Hye, et al.
Publicado: (2022)

Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells
por: Clement, Michelle Simone, et al.
Publicado: (2020)

Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells
por: Xiao, Juanjuan, et al.
Publicado: (2019)

MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling
por: Huang, Na, et al.
Publicado: (2015)

MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4
por: Hu, Jiajia, et al.
Publicado: (2012)

p55PIK Transcriptionally Activated by MZF1 Promotes Colorectal Cancer Cell Proliferation
por: Deng, Yu, et al.
Publicado: (2013)

miR‐944 inhibits metastasis of gastric cancer by preventing the epithelial–mesenchymal transition via MACC1/Met/AKT signaling
por: Pan, Tao, et al.
Publicado: (2017)

Design, Synthesis, and Evaluation of New Mesenchymal–Epithelial Transition Factor (c-Met) Kinase Inhibitors with Dual Chiral Centers
por: Yao, Han, et al.
Publicado: (2022)

Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway
por: Wang, Guihua, et al.
Publicado: (2017)

Elevated FAM3C promotes cell epithelial– mesenchymal transition and cell migration in gastric cancer
por: Shi, Mengyue, et al.
Publicado: (2018)

Correction: Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway
por: Wang, Guihua, et al.
Publicado: (2021)

EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis
por: Huang, Changsheng, et al.
Publicado: (2022)

Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation
por: Prasad, Ram Raj, et al.
Publicado: (2021)

Endogenous Pancreatic Cancer Cell PD-1 Activates MET and Induces Epithelial-Mesenchymal Transition to Promote Cancer Progression
por: Harper, Megan M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2nn94e93ujel1ta5vfu94u0rpe